Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07032116

YiqiJiangzhuoHuoxueTongluo Method to Delay the Occurrence of End-stage Renal Disease in Diabetic Kidney Disease--Study1

Evidence-based Evaluation of Yiqi Jiangzhuo Huoxue Tongluo Method in Delaying the Occurrence of End-stage Renal Disease in Diabetic Kidney Disease--Study 1

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
4,472 (estimated)
Sponsor
Liu Hongfang · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

In order to reduce the clinical demand for kidney dialysis rate of Diabetic Kidney Disease(DKD) patients, a bidirectional cohort study of 4472 patients with DKD (Qi deficiency and collateral stasis syndrome) was carried out based on a preliminary DKD cohort of 13,000 patients. The exposure factor was supplementing and reducing the kidney turbidity-Huoxue Tongluo method represented by the addition and subversion of Shenzhuo prescription, and the incidence of end-stage renal disease was the main therapeutic index. Follow-up was conducted for 2 years

Conditions

Timeline

Start date
2025-08-01
Primary completion
2028-07-31
Completion
2028-07-31
First posted
2025-06-22
Last updated
2025-06-22

Locations

5 sites across 1 country: China

Source: ClinicalTrials.gov record NCT07032116. Inclusion in this directory is not an endorsement.